Cargando…
The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas
BACKGROUND: Studies have shown that long noncoding RNAs (lncRNAs) make up the major proportion of the ceRNA network and can regulate gene expression by competitively binding to miRNAs. This reveals the existence of an RNA-miRNA regulatory pathway and is of great biological significance. CeRNAs, as c...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301306/ https://www.ncbi.nlm.nih.gov/pubmed/30588106 http://dx.doi.org/10.2147/CMAR.S182521 |
_version_ | 1783381812933820416 |
---|---|
author | Gao, Chundi Li, Huayao Zhuang, Jing Zhang, HongXiu Wang, Kejia Yang, Jing Liu, Cun Liu, Lijuan Zhou, Chao Sun, Changgang |
author_facet | Gao, Chundi Li, Huayao Zhuang, Jing Zhang, HongXiu Wang, Kejia Yang, Jing Liu, Cun Liu, Lijuan Zhou, Chao Sun, Changgang |
author_sort | Gao, Chundi |
collection | PubMed |
description | BACKGROUND: Studies have shown that long noncoding RNAs (lncRNAs) make up the major proportion of the ceRNA network and can regulate gene expression by competitively binding to miRNAs. This reveals the existence of an RNA-miRNA regulatory pathway and is of great biological significance. CeRNAs, as competitive endogenous RNAs, have revealed a new mechanism of interaction between RNAs. Until now, the role of lncRNA-mediated ceRNAs in breast cancer and their regulatory mechanisms have been elucidated to some extent. PURPOSE: In this study, comprehensive analysis of large-scale invasive breast cancer samples in TCGA were conducted to further explore the developmental mechanism of invasive breast cancer and the potential predictive markers for invasive breast cancer prognosis in the ceRNA network. METHODS: Abnormal expression profiles of invasive breast cancer associated mRNAs, lncRNAs and miRNAs were obtained from the TCGA database. Through further alignment and prediction of target genes, an abnormal lncRNA-miRNA-mRNA ceRNA network was constructed for invasive breast cancer. Through the overall survival analysis, Identification prognostic bio-markers for invasive breast cancer patients. In addition, we used Cytoscape plug-in BinGo for the different mRNA performance functional cluster analysis. RESULTS: Differential analysis revealed that 1059 lncRNAs, 86 miRNAs, and 2138 mRNAs were significantly different in invasive breast cancer samples versus normal samples. Then we construct an abnormal lncRNA-miRNA-mRNA ceRNA network for invasive breast cancer, consisting of 90 DElncRNAs, 18 DEmiRNAs and 26 DEmRNAs.Further, 4 out of 90 lncRNAs, 3 out of 26 mRNAs, and 2 out of 18 miRNAs were useful as prognostic biomarkers for invasive breast cancer patients (P value < 0.05). It is worth noting that based on the ceRNA network, we found that the LINC00466-Hsa-mir-204- NTRK2 LINC00466-hsa-mir-204-NTRK2 axis was present in 9 RNAs associated with the prognosis of invasive breast cancer. CONCLUSION: This study provides an effective bioinformatics basis for further understanding of the molecular mechanism of invasive breast cancerand for predicting outcomes, which can guide the use of invasive breast cancerdrugs and subsequent related research. |
format | Online Article Text |
id | pubmed-6301306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-63013062018-12-26 The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas Gao, Chundi Li, Huayao Zhuang, Jing Zhang, HongXiu Wang, Kejia Yang, Jing Liu, Cun Liu, Lijuan Zhou, Chao Sun, Changgang Cancer Manag Res Original Research BACKGROUND: Studies have shown that long noncoding RNAs (lncRNAs) make up the major proportion of the ceRNA network and can regulate gene expression by competitively binding to miRNAs. This reveals the existence of an RNA-miRNA regulatory pathway and is of great biological significance. CeRNAs, as competitive endogenous RNAs, have revealed a new mechanism of interaction between RNAs. Until now, the role of lncRNA-mediated ceRNAs in breast cancer and their regulatory mechanisms have been elucidated to some extent. PURPOSE: In this study, comprehensive analysis of large-scale invasive breast cancer samples in TCGA were conducted to further explore the developmental mechanism of invasive breast cancer and the potential predictive markers for invasive breast cancer prognosis in the ceRNA network. METHODS: Abnormal expression profiles of invasive breast cancer associated mRNAs, lncRNAs and miRNAs were obtained from the TCGA database. Through further alignment and prediction of target genes, an abnormal lncRNA-miRNA-mRNA ceRNA network was constructed for invasive breast cancer. Through the overall survival analysis, Identification prognostic bio-markers for invasive breast cancer patients. In addition, we used Cytoscape plug-in BinGo for the different mRNA performance functional cluster analysis. RESULTS: Differential analysis revealed that 1059 lncRNAs, 86 miRNAs, and 2138 mRNAs were significantly different in invasive breast cancer samples versus normal samples. Then we construct an abnormal lncRNA-miRNA-mRNA ceRNA network for invasive breast cancer, consisting of 90 DElncRNAs, 18 DEmiRNAs and 26 DEmRNAs.Further, 4 out of 90 lncRNAs, 3 out of 26 mRNAs, and 2 out of 18 miRNAs were useful as prognostic biomarkers for invasive breast cancer patients (P value < 0.05). It is worth noting that based on the ceRNA network, we found that the LINC00466-Hsa-mir-204- NTRK2 LINC00466-hsa-mir-204-NTRK2 axis was present in 9 RNAs associated with the prognosis of invasive breast cancer. CONCLUSION: This study provides an effective bioinformatics basis for further understanding of the molecular mechanism of invasive breast cancerand for predicting outcomes, which can guide the use of invasive breast cancerdrugs and subsequent related research. Dove Medical Press 2018-12-17 /pmc/articles/PMC6301306/ /pubmed/30588106 http://dx.doi.org/10.2147/CMAR.S182521 Text en © 2019 Gao et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Gao, Chundi Li, Huayao Zhuang, Jing Zhang, HongXiu Wang, Kejia Yang, Jing Liu, Cun Liu, Lijuan Zhou, Chao Sun, Changgang The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas |
title | The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas |
title_full | The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas |
title_fullStr | The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas |
title_full_unstemmed | The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas |
title_short | The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas |
title_sort | construction and analysis of cerna networks in invasive breast cancer: a study based on the cancer genome atlas |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301306/ https://www.ncbi.nlm.nih.gov/pubmed/30588106 http://dx.doi.org/10.2147/CMAR.S182521 |
work_keys_str_mv | AT gaochundi theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT lihuayao theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT zhuangjing theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT zhanghongxiu theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT wangkejia theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT yangjing theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT liucun theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT liulijuan theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT zhouchao theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT sunchanggang theconstructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT gaochundi constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT lihuayao constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT zhuangjing constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT zhanghongxiu constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT wangkejia constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT yangjing constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT liucun constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT liulijuan constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT zhouchao constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas AT sunchanggang constructionandanalysisofcernanetworksininvasivebreastcancerastudybasedonthecancergenomeatlas |